ALBCURA CORPORATION
Update:2026/01/07
Industries
Main Industry
Biotechnology
Main Product/Service
Albcura’s flagship product line, deAlbumin™, is recombinant human serum albumin (rHSA) produced in yeast (e.g., Pichia pastoris), formulated with a well-defined recipe to eliminate plasma-derived impurities and ensure batch-to-batch consistency. This enab
Founded Year
2017
Unified Business No.
52534104
Status
Active
Number of Employees
0
Total Paid-in
Capital
189,952,920 (NT$)
Location of Company
Taiwan
, New Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Albcura Corporation, headquartered in Taiwan, is a biotechnology startup specializing in the development and production of high-quality, animal-component-free recombinant human serum albumin (rHSA). Their products are designed for applications in cell cul